Filing Details

Accession Number:
0001576280-21-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-12 20:21:43
Reporting Period:
2021-02-10
Accepted Time:
2021-02-12 20:21:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753159 Amirali Talasaz 505 Penobscot Drive
Redwood City CA 94063
Chairman, President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-11 5,632 $168.35 471,781 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 981 $169.12 470,800 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.74 to $168.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.74 to $169.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.